Related Experiment Video
Updated: Jul 30, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Present status and future prospects for HIV therapies
1Basic Research and Development Program, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892.
Science (New York, N.Y.)
|May 28, 1993
Summary
Significant progress in anti-human immunodeficiency virus (HIV) drug development has been made, yet challenges like drug resistance and immune system restoration persist. Further research into HIV pathogenesis is crucial for effective therapeutic strategies.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Human immunodeficiency virus (HIV) was discovered in 1983.
- Substantial advancements have been achieved in developing anti-HIV medications.
- Current HIV therapies are primarily palliative, with significant challenges remaining.
Purpose of the Study:
- To review the progress in anti-HIV drug discovery and development.
- To highlight the emerging obstacles in HIV treatment, including drug resistance and immunopathogenesis.
- To emphasize the need for deeper insights into HIV pathogenesis for therapeutic advancement.
Main Methods:
- In vitro screening against whole virus.
- Screening against specific viral targets.
- Analysis of emerging data on immunopathogenesis.
Main Results:
- Development of clinical candidates targeting critical stages of the HIV life cycle.
- Recognition of HIV drug resistance as a major obstacle.
- Emerging data suggest potential long-term immune system dysfunction even after viral elimination.
Conclusions:
- Despite progress, HIV therapy faces significant hurdles including drug resistance and immune restoration.
- Deeper understanding of HIV pathogenic mechanisms is essential for therapeutic gain.
- Continued public and private sector collaboration and funding are vital for advancing HIV research.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...